Profit Or Loss [Abstract]

Captor Therapeutics S.A. - Filing #6216905

Concept	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue	—	3 986 PLN	—	—	—	—
Cost of sales	—	741,000 PLN	—	—	—	—
Gross profit	—	3 245 PLN	—	—	—	—
Other income	—	2 694 PLN	—	—	126,000 PLN	—
Administrative expenses	—	19 545 PLN	—	—	4 202 PLN	—
Other expense, by function	—	5 804 PLN	—	—	378,000 PLN	—
Profit (loss) from operating activities	—	31 709 PLN	—	—	12 216 PLN	—
Finance costs	—	863,000 PLN	—	—	478,000 PLN	—
Profit (loss) before tax	—	32 572 PLN	—	—	12 694 PLN	—
Profit (loss) from continuing operations	—	32 572 PLN	—	—	12 694 PLN	—
Profit (loss)	32 572 PLN	32 572 PLN	32 572 PLN	12 694 PLN	12 694 PLN	12 694 PLN
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent	—	32 572 PLN	—	—	12 694 PLN	—
Earnings per share [text block]	—	—	—	—	—	—
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share	—	789,000	—	—	354,000	—
Diluted earnings per share [abstract]
Diluted earnings (loss) per share	—	748,000	—	—	381,000	—